Background Immunosuppression and comorbidities increase the risk of severe coronavirus
disease-2019 (COVID-19) in solid organ transplant (SOT) recipients. The outcomes of …

The COVID-19 pandemic has had considerable impact on alcohol use, with an increase in
alcohol related emergencies, changes in alcohol use patterns, increased risk of contracting …

Globally, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2 virus) has
been a major cause for significant morbidity and mortality. Since the start of the pandemic …

Background Italy has been the first Western country to be heavily affected by the spread of
SARS-COV-2 infection and among the pioneers of the clinical management of pandemic. To …

The new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
identified in December 2019, in Wuhan, China. The virus was rapidly spread worldwide …

Background COVID-19 continues to pose a significant healthcare challenge throughout the
world. Comorbidities including diabetes and hypertension are associated with a significantly …

METHODS: Consecutive patients with COVID-19, diagnosed in a university hospital referral
laboratory in northern India, were evaluated for clinical manifestations including GI …

BACKGROUND Chronic liver disease, particularly cirrhosis, is associated with worse
outcomes in patients infected with coronavirus disease 2019 (COVID-19). AIM To assess …

The epidemic of coronavirus disease 2019 (COVID-19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has increasingly attracted worldwide …

Coronavirus disease 2019 (COVID-19) is associated with a significant morbidity and
mortality in patients with cirrhosis. There is a significantly higher morbidity and mortality due …